PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China.\', \'Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, P.R. China.\', \'State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, P.R. China.\', \'National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health & School of Life Science, Xiamen University, Xiamen, P.R. China.\', \'Department of Laboratory, Wuhan Blood Center, Wuhan, P.R. China.\', \'Confirmation Laboratory for Transfusion Transmitted Disease, Institute of Blood Transfusion of Hubei Province, Wuhan, P.R. China.\', \'Blood Screening Laboratory, Hebei Province Blood Center, Shijiazhuang, P.R. China.\', \'Shenzhen Blood Center, Shenzhen, P.R. China.\', \'Wuhan Blood Center, Wuhan, P.R. China.\', \'Department of Transfusion Research, Wuhan Blood Center, Wuhan, P.R. China.\', \'State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, P.R. China. yuanquan@xmu.edu.cn.\', \'National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health & School of Life Science, Xiamen University, Xiamen, P.R. China. yuanquan@xmu.edu.cn.\', \'National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, P.R. China. lunan99@163.com.\', \'Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, P.R. China. lunan99@163.com.\', \'Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, P.R. China. lunan99@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-21503-x
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33654063
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • The prevalence of antibodies to SARS-CoV-2 among blood donors in China.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33654063>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33654063>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all